Workshops Based on the A-MAb Case Study
Members of the CMC Biotech Working Group will participate in various public workshops hosted by ISPE and CASSS, who have been designated as the primary facilitators of education related to the A-MAb Case Study. Sessions will be held during three 2010 CASSS events, including the CMC Strategy Forum Europe [http://www.casss.org/cde.cfm?event=265809] in Vienna, in April, and the CMC Strategy Forum [ http://www.casss.org/cde.cfm?event=285435] in Bethesda, MD, in July. Workshops also will be incorporated into already scheduled ISPE 2010 meetings, in Milan [http://www.ispe.org/milancongress] in March, Tokyo [http://www.ispe.org/cs/root/education_and_training/events/japan_affiliate_annual_meeting_including_pqli] in April, Washington, DC [http://www.ispe.org/2010washingtonconference], in June, and Brussels [http://www.ispe.org/cs/2010_brussels_conference/conference_programme] in September.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.
Filter Sizing for Process Optimization in Life Sciences Sterile Filtration
April 24th 2025Bench-scale filterability studies play a critical role in optimizing sterile filtration in biopharmaceutical manufacturing. By guiding the selection and sizing of filters, these studies help streamline processes, improve scalability, and reduce costs. Through data-driven case studies, this paper highlights how the strategic use of pre-filters and membrane materials can maximize throughput and minimize filter fouling.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.
Filter Sizing for Process Optimization in Life Sciences Sterile Filtration
April 24th 2025Bench-scale filterability studies play a critical role in optimizing sterile filtration in biopharmaceutical manufacturing. By guiding the selection and sizing of filters, these studies help streamline processes, improve scalability, and reduce costs. Through data-driven case studies, this paper highlights how the strategic use of pre-filters and membrane materials can maximize throughput and minimize filter fouling.
2 Commerce Drive
Cranbury, NJ 08512